Clinical Trials Browser

Glioma × veliparib × 90 days × Clear all

NCT03581292 2026-05-27

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Phase 2 Active not recruiting

38 enrolled 13 charts

Astrocytoma, Glioblastoma, Glioma